Reich Kristian

Reich Kristian is listed in filings as Chief Scientific Officer at MoonLake Immunotherapeutics. This profile follows SEC Form 4 activity through Jan 9, 2026, including sale activity. Recent filings connect the profile to MoonLake Immunotherapeutics (MLTX). The current snapshot covers public activity from Jan 22, 2025 to Jan 9, 2026. Reported amounts are shown as $5.8M to $2.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.